Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 4 (2007), Issue 9 (September)

1. Evaluation of early and late toxicities in chemoradiation trials.
   J Clin Oncol, 25(26): 4096-103. [Abstract] [Full-text]
2. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
   Am J Surg, 194(4): 507-10. [Abstract] [Full-text]
3. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
   Am J Surg, 194(4): 456-62. [Abstract] [Full-text]
4. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
   Cancer, 110(6): 1345-50. [Abstract] [Full-text]
5. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
   Cancer, 110(6): 1329-37. [Abstract] [Full-text]
6. Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.
   Neurology, 69(11): 1178-82. [Abstract] [Full-text]
7. Evaluation of uncertainty-based stopping criteria for monte carlo calculations of intensity-modulated radiotherapy and arc therapy patient dose distributions.
   Int J Radiat Oncol Biol Phys, 69(2): 628-37. [Abstract] [Full-text]
8. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
   Int J Radiat Oncol Biol Phys, 69(2): 619-27. [Abstract] [Full-text]
9. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
   Int J Radiat Oncol Biol Phys, 69(2): 614-8. [Abstract] [Full-text]
10. Experimental evaluation of the impact of different head-and-neck intensity-modulated radiation therapy planning techniques on doses to the skin and shallow targets.
    Int J Radiat Oncol Biol Phys, 69(2): 607-13. [Abstract] [Full-text]
11. On-board patient positioning for head-and-neck IMRT: comparing digital tomosynthesis to kilovoltage radiography and cone-beam computed tomography.
    Int J Radiat Oncol Biol Phys, 69(2): 598-606. [Abstract] [Full-text]
12. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.
    Int J Radiat Oncol Biol Phys, 69(2): 589-97. [Abstract] [Full-text]
13. Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.
    Int J Radiat Oncol Biol Phys, 69(2): 572-9. [Abstract] [Full-text]
14. Correlation of traditional point a with anatomic location of uterine artery and ureter in cancer of the uterine cervix.
    Int J Radiat Oncol Biol Phys, 69(2): 498-503. [Abstract] [Full-text]
15. Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 69(2): 469-74. [Abstract] [Full-text]
16. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 69(2): 426-33. [Abstract] [Full-text]
17. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
    Int J Radiat Oncol Biol Phys, 69(2): 475-82. [Abstract] [Full-text]
18. Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
    Am J Hematol, 82(10): 863-6. [Abstract] [Full-text]
19. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Int J Radiat Oncol Biol Phys, 69(2): 404-10. [Abstract] [Full-text]
20. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
    Int J Radiat Oncol Biol Phys, 69(2): 504-11. [Abstract] [Full-text]
21. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
    Int J Radiat Oncol Biol Phys, 69(2): 454-8. [Abstract] [Full-text]
22. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
    Int J Radiat Oncol Biol Phys, 69(2): 444-53. [Abstract] [Full-text]
23. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
    Int J Radiat Oncol Biol Phys, 69(2): 381-9. [Abstract] [Full-text]
24. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.
    Int J Radiat Oncol Biol Phys, 69(2): 419-25. [Abstract] [Full-text]
25. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Int J Radiat Oncol Biol Phys, 69(2): 459-68. [Abstract] [Full-text]
26. Three-dimensional non-coplanar conformal radiotherapy yields better results than traditional beam arrangements for adjuvant treatment of gastric cancer.
    Int J Radiat Oncol Biol Phys, 69(2): 364-9. [Abstract] [Full-text]
27. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Int J Radiat Oncol Biol Phys, 69(2): 350-7. [Abstract] [Full-text]
28. Efficacy and quality of life outcomes in patients with atypical trigeminal neuralgia treated with gamma-knife radiosurgery.
    Int J Radiat Oncol Biol Phys, 69(2): 397-403. [Abstract] [Full-text]
29. Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.
    Transplantation, 84(5): 619-28. [Abstract] [Full-text]
30. Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG).
    J Clin Oncol, 25(27): 4239-45. [Abstract] [Full-text]
31. Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapy.
    J Clin Oncol, 25(27): 4285-92. [Abstract] [Full-text]
32. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging.
    Eur J Vasc Endovasc Surg, 34(4): 416-23. [Abstract] [Full-text]
33. Hyperfractionated accelerated radiotherapy in locally advanced head and neck cancers.
    Onkologie, 30(10): 479-84. [Abstract] [Full-text]
34. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer.
    Int J Radiat Oncol Biol Phys, 69(3): 955-61. [Abstract] [Full-text]
35. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
    Int J Radiat Oncol Biol Phys, 69(3): 944-54. [Abstract] [Full-text]
36. Technical evaluation of radiation dose delivered in prostate cancer patients as measured by an implantable MOSFET dosimeter.
    Int J Radiat Oncol Biol Phys, 69(3): 925-35. [Abstract] [Full-text]
37. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?
    Int J Radiat Oncol Biol Phys, 69(3): 918-24. [Abstract] [Full-text]
38. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer.
    Int J Radiat Oncol Biol Phys, 69(3): 711-5. [Abstract] [Full-text]
39. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 69(3): 761-9. [Abstract] [Full-text]
40. Outcome after pituitary radiosurgery for thalamic pain syndrome.
    Int J Radiat Oncol Biol Phys, 69(3): 852-7. [Abstract] [Full-text]
41. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Int J Radiat Oncol Biol Phys, 69(3): 839-45. [Abstract] [Full-text]
42. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.
    Int J Radiat Oncol Biol Phys, 69(3): 813-9. [Abstract] [Full-text]
43. Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer.
    Int J Radiat Oncol Biol Phys, 69(3): 800-4. [Abstract] [Full-text]
44. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 69(3): 825-30. [Abstract] [Full-text]
45. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Int J Radiat Oncol Biol Phys, 69(3): 656-61. [Abstract] [Full-text]
46. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Int J Radiat Oncol Biol Phys, 69(3): 662-70. [Abstract] [Full-text]
47. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.
    Int J Radiat Oncol Biol Phys, 69(3): 793-9. [Abstract] [Full-text]
48. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study.
    Cancer, 110(7): 1485-92. [Abstract] [Full-text]
49. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
    Cancer, 110(7): 1405-16. [Abstract] [Full-text]
50. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Cancer, 110(7): 1551-9. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.